[1] 李丰田, 杨继勇, 叶丽艳, 等. 2007-2012年肠杆菌科细菌分布及耐药性分析[J]. 中华医院感染学杂志, 2014, 24(24):6004-6005. [2] Levy SB, Antibacterial resistance worldwide:causes, challenges and responses[J]. Nature Medicine, 2004, 10(12):122-129. [3] 肖永红, 沈萍, 魏泽庆, 等. Mohnarin 2010年度全国细菌耐药监测[J]. 中华医院感染学杂志. 2011, 21(23):4896-4902. [4] 吕瑞勤, 郗砚彬, 吕金玲, 等. 第四代喹诺酮类抗菌药物研究进展[J]. 中国新药杂志, 2012, 21(13):1485-1493. [5] Chen XH, Zhang BW, Li H, et al.Myo-inositol improves the host’s ability to eliminate balofloxacin-resistant Escherichia coli[J]. Scientific Reports, 2015, 5(1):10720. [6] Lin X, Lin L, Yao Z, et al.An integrated quantitative and targeted proteomics reveals fitness mechanisms of Aeromonas hydrophila under oxytetracycline stress[J]. Journal of Proteome Research, 2015, 14(3):1515-1525. [7] Szklarczyk D, Franceschini A, Wyder S, et al.STRING v10:protein-protein interaction networks, integrated over the tree of life[J]. Nucleic Acids Res, 2015, 43(D1):D447-D452. [8] Clifford RJ, Milillo M, Prestwood J, et al.Detection of bacterial 16S rRNA and identification of four clinically important bacteria by real-time PCR[J]. PLoS One, 2012, 7(11):e48558. [9] Betanzoscabrera G, Juárezverdayes MA, Gonzálezgonzález G, et al.Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidiss trains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis[J]. Ophthalmic Research, 2009, 42(1):43-48. [10] Masi M, Réfregiers M, Pos MK, et al.Mechanisms of envelope permeability and antibiotic influx and efflux in Gram-negative bacteria[J]. Nature Microbiology, 2017, 2(3):17001. [11] Peng B, Wang C, Li H, et al.Outer membrane proteins form specific patterns in antibiotic-resistant Edwardsiella tarda[J]. Frontiers in Microbiology, 2017, 8(69):1-12. [12] Tamae C, Liu A, et al.Determination of antibiotic hypersensitivity among 4, 000 single-gene-knockout mutants of Escherichia coli[J]. J Bacteriol, 2008, 190(17):5981-5988. [13] Nikaido H.Molecular basis of bacterial outer membrane permeabilityr evisited[J]. Microbiology and Molecular Biology Reviews, 2003, 67(4):593-656. [14] Lin XM, Li H, Wang C, et al.Proteomic analysis of nalidixic acid resistance in Escherichia coli:identification and functional characterization of OM proteins[J]. Journal of Proteome Research, 2008, 7(1):2399-2405. [15] Liu YF, Yan JJ, Lei HY, et al.Loss of outer membrane protein C in Escherichia coli contributes to both antibiotic resistance and escaping antibody-dependent bactericidal activity[J]. Infection and Immunity, 2012. 80(5):1815-1822. [16] Lin XM, Wang C, et al.Differential regulation of OmpC and OmpF by AtpB in Escherichia coli exposed to nalidixic acid and chlortetracycline[J]. J Proteomics, 2012, 75(18):5898-5910. [17] Peng XX, Xu CX, Ren HX, et al.Proteomic analysis of the sarcosine-insoluble outer membrane fraction of Pseudomonas aeruginosa responding to ampicilin, kanamycin, and tetracycline resistance[J]. Journal of Proteome Research, 2005. 4(6):2257-2265. [18] Peng B, Su YB, Li H, et al.Exogenous alanine and/or glucose plus kanamycin kills antibiotic-resistant bacteria[J]. Cell Metabolism, 2015, 21(2):249-262. [19] Su YB, Peng B, Li H, et al.Pyruvate cycle increases aminoglycoside efficacy and provides respiratory energy in bacteria[J]. Proc Natl Acad Sci USA, 2018, 115(7):1578-1587. [20] Li WX, Yao ZJ, Sun LN, et al.Proteomics analysis reveals a potential antibiotic cocktail therapy strategy for Aeromonas hydrophila infection in biofilm[J]. Journal of Proteome Research, 2016, 15(6):1810-1820. [21] Cheng ZX, Yang MJ, Peng B, et al.The depressed central carbon and energy metabolisms is associated to the acquisition of levofloxacin resistance in Vibrio alginolyticus[J]. J Proteomics, 2018, 181:83-91. [22] George AJ.Mechanisms of resistance to quinolones[J]. Clinical Infectious Diseases, 2005, 41:S120-S126. |